Oncostatin M-induced growth inhibition and morphological changes of MDA-MB231 breast cancer cells are abolished by blocking the MEK/ERK signaling pathway

Breast Cancer Research and Treatment

Volumn 66, Issue 2, 2001, Pages 111-121

  Li, C ^a   Ahlborn, T E ^a   Kraemer, F B ^a   Liu, J ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Breast cancer cell growth; ERK; Oncostatin M; Signal transduction

Indexed keywords

ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; ONCOSTATIN M; PROTEIN P21; PROTEIN P27; STAT1 PROTEIN; STAT3 PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; MAP KINASE KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOSTATIN M; PEPTIDES; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 0035016664     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010614724664     Document Type: Article

References (43)

1. Oncostatin M: A growth regulator produced by differentiated lymphoma cells
2. Purification and characterization of cytostatic lymphokines produced by activated human T-lymphocytes: Synergistic antiproliferative activity of transforming growth factor β1, interferon γ and oncostatin M for human melanoma cells
3. Macrophages-derived factors increase low-density lipoprotein uptake and receptor number in cultured human liver cells
4. Regulation of cell growth by recombinant oncostatin M
5. Oncostatin M induces the differentiation of breast cancer cells
6. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene
7. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells
8. The oncostatin M signalling pathway: Reversing the neoplastic phenotype?
9. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells
10. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M
11. Transcriptional suppression of synuclein gamma (SNCG) expression in human breast cancer cells by the growth inhibitory cytokine oncostatin M
12. Association and activation of Jak-Tyk kinase by CNTF-LIF-OSM-IL-6β receptor components
13. Jak-STAT pathways and transcriptional activation in response to INFs and other extracellular signaling proteins
14. Aromatase P450 gene expression in human adipose tissue: Role of a JAK/STAT pathway in regulation of the adipose-specific promoter
15. Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway
16. Activation of the Janus Kinase/STAT (signal transduction and activator of transcription) signal transduction pathway by interleukin-6 type cytokines promotes osteoblast differentiation
17. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes
18. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L 1 cells
19. Activation of Raf- 1 by interferon y and oncostatin M requires expression of the Stat1 transcription factor
20. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
21. Beta interferon and oncostatin M activate Raf-1 and mitogen-activated protein kinase through a JAK1-dependent pathway
22. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
23. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis
24. Stat3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line
25. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for STAT3 activation
26. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
27. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
28. Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M
29. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
30. Constitutive activation of the 41/43-kda mitogen-activated protein kinase signaling pathway in human tumors
31. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in intro and in vivo
32. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
33. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes
34. WAF1,CIP1,SDI1 gene by interleukin-6 type cytokines
35. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1
36. Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation
37. Identification of the interleukin6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
38. Regulation of transcription by MAP kinase cascades
39. Integration of MAP kinase signal transduction pathways at the serum response element
40. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates
41. ERK phosphorylation potentiates ELK-1-mediated ternary complex formation and transactivation
42. Retinoic acid induced mitogen activated protein (MAP)/Extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest
43. Regulation and properties of extracellular signal-regulated protein kinase 1 and 2 in vitro